Navigation Links
Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and,Maintenance vs. Placebo

significance. For TST, the 50 mg dose achieved significance (p=0.024) and the 20 and 100 mg doses showed a trend toward significance.

"VEC-162 induces and maintains sleep by modulating the sleep/wake cycle," said Paolo Baroldi, M.D., Ph.D., Chief Medical Officer, Vanda Pharmaceuticals Inc. "The subjective findings suggest the compound's unique mechanism of action provides a noticeable improvement in overall sleep quality."

About Insomnia

Approximately 70 million American adults experience insomnia of all types, characterized by difficulty falling asleep, waking frequently during the night, waking too early and not being able to return to sleep, or waking up not feeling refreshed. Circadian Rhythm Sleep Disorders (CRSD), one type of insomnia, affect millions of Americans in a number of forms. Shift Worker Sleep Disorder is a CRSD affecting the 14% of Americans who are shift workers. Another CRSD type is Delayed Sleep Phase Syndrome, which affects 5-10% of patients in sleep disorder clinics and accounts for 40% of disorders involving sleep-wake schedules.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc., headquartered in Rockville, Maryland, is a biopharmaceutical company working to advance the science of personalized medicine to improve the lives of patients with various CNS disorders, including insomnia and schizophrenia. The company has three product candidates in clinical development. Vanda's lead product candidate, iloperidone, is a compound for the treatment of schizophrenia and has completed its Phase III program. Vanda's second product candidate, VEC-162, is a compound for the treatment of sleep and mood disorders which is currently in Phase III for insomnia. Vanda's third product candidate, VSF-173, is a compound in Phase II for the treatment of excessive sleepiness. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com .

N
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
4. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
5. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
6. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
7. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Nymox Announces NX-1207 Data to Be Presented at Upcoming U.S. Urology Meetings
10. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
11. New Data Presented on Micardis (Telmisartan) Tablets in Hypertensive Patients With Type 2 Diabetes
Post Your Comments:
(Date:7/2/2009)... LEUVEN, Belgium and LUND, Sweden, July 3 /PRNews...ssels: THR) and co-development partner,BioInvent ... started,recruitment of a second cohort of patien...ws completion of recruitment of the first cohort o...el, long acting anticoagulant that,is being devel...
(Date:7/2/2009)...KYO and WOODCLIFF LAKE, N.J., July 2 /PRNewswire/ ... & CEO: Haruo Naito, "Eisai") and Eisai Corpor...ke, NJ, Chairman and CEO Hajime Shimizu) are curre...ms for the company,s major product Aricept(R) (don...e to patients with Alzheimer,s disease. As progres...
(Date:7/1/2009)... KVISTGAARD, Denmark, July 1 /PRNewswire-FirstCal..."Expert Opinion on Investigational Drugs", Volume,... information on,PROSTVAC(TM). This is the most co... far. , Quote from the article: "Preliminar...ity, and Phase II trials have suggested a survival...
(Date:6/30/2009)...DLOTHIAN, Va., June 30 In two rece...s nebulizer and PRONEB compressors (Ultra and Ultr...fumarate (Perforomist, DEY LP, Mylan Inc.) improve... researchers chose PARI products as the exclusive ...ntenance treatments for COPD. Sutherland et al. u...
Breaking Medicine Technology:ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 5Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 2Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value 3New Review on PROSTVAC(TM) Published by Key Investigators From NCI 2PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 2Details of evolutionary transition from fish to land animals revealed 5398 1Details of evolutionary transition from fish to land animals revealed 5398 2Breaking News 3A Finally 21 A Catholic Bishop Confirms that a Catholic Cannot Vote for Obama in Good Conscience 27385 1Breaking News 3A Finally 21 A Catholic Bishop Confirms that a Catholic Cannot Vote for Obama in Good Conscience 27385 2KePROs Chief Medical Officer to Present and Participate in Physician Roundtable at McKesson Health Solutions Conference 27383 1KePROs Chief Medical Officer to Present and Participate in Physician Roundtable at McKesson Health Solutions Conference 27383 2Darwin Stockholders Adopt Merger Agreement with Allied World 27381 1Darwin Stockholders Adopt Merger Agreement with Allied World 27381 2Darwin Stockholders Adopt Merger Agreement with Allied World 27381 3
... of concept in topical models of,infection , REINA....,(SWX: ARPN) today announced positive results of ...nst a large panel of,clinical isolates, including ...ddition, topical applications of AR-2474 were foun...n resistant,Staphylococcus aureus (MRSA) in precli...
...7--The World Health Organization,has released new ...akistan. , So is this another instance where, as l... industry is denying important vaccines to,poor po...don’s Guardian,newspaper, “parents of ...low health workers to administer polio vaccination...
Other Medicine Technology:Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 2Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 3Why Is Polio Spreading in Pakistan? 2
(Date:7/2/2009)...wire/ -- Recent news reports have highlighted the ...hat physicians meet high standards in their chosen... of Medical Specialties (ABMS), which coordinates ...to develop and implement educational and professio... of physician specialists. Certification by an AB...
(Date:7/2/2009)...wire/ -- Pro-life forces won an important battle y...ld a state law regulating that abortion centers mu... RU-486 (also known as the "abortion pill") in ord... , , The ruling came in Rogers v. Planned Pare...04 law requiring that those administering RU-486 c...
(Date:7/2/2009)...honored in Washington, D.C. , , ARLINGTON, Tex...th Resources has received the Best Employers for ...ss Group on Health. , , (Logo: http://www.ne..., , The award recognizes the nation,s leading co...healthy workplace and for helping employees and th...
(Date:7/2/2009)... threat, expert says , , THURSDAY, July... certain species of wildlife, which need to be pro... , "Cancer is one of the leading health concern...of human deaths. But we now understand that cancer...hor Denise McAloose, chief pathologist for the Wil...
Breaking Medicine News(10 mins):Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 2Health News:Texas Health Resources Recognized by National Business Group on Health as Leading Employer Promoting Healthy Lifestyles for Employees 3Health News:Cancer Endangers Some Wildlife Species 2
... have discovered a naturally occurring hormone tha...%. Mice lacking the gene for klotho began showing ...e and die after // about two months when compared ...is has indeed opened up new avenues into improving...
... report published in the latest edition of The Lan...n treating adults with malaria than the common dru...r the treatment // of severe malaria throughout Af... But even with prompt administration of the drug i...
...ug 26 . Japanese encephalitis deaths continue to r...ed 220 in less than a month. // Dr.T.N.Dhole from...i Post Graduate Institute of Medical Sciences bla... spread of the killer brain fever, which had been ...
...n country of Uganda reports that all the efforts t...ing. The report on this topic was reported in this...nosoma brucei rhodesiense sleeping // sickness in ...lt of the movement of the livestock reservoir of t...
Other Medicine News:Health News:Encephalitis Deaths Cross 220 in Uttar Pradesh 2
The 30° Prism is designed for midperipheral fundus pathologies and are recommended for tractional retinal detachments (PDR, BRVO etc.) and Rhegmatogenus retinal detachment. They can be used for p
The High-Mag 1.5x is specifically designed for internal limiting membrane peeling in macular hole surgery, optic nerve neurotomy, sheathotomy and macularepiretinal membrane removal, traditional macul
...resolution, high magnification and field of view a...gn separates for easy cleaning, while maintaining ...d saline or water to the contact element, then loc...enses The ACS Vitrectomy Lenses from Volk can be s...
...e DynaView 156 is designed to attain a full field ... both premature infants and adult patients. Featur...lement, the Volk DynaView 156 revolutionizes retin...equirement for lens sparing vitrectomies in ROP. I...
Medicine Products: